Close

Ratings by Dawson James (Jason Kolbert)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/20/2024 Know Labs KNW Downgrade Neutral
(Buy)
0.49
(0.47)
-4.08% Details
12/28/2023 CytoSorbents CTSO Maintain Buy
(N/A)
 
 
  Details
11/14/2023 Zomedica ZOM Downgrade Neutral
(Buy)
0.18
(0.12)
-33.33% Details
11/13/2023 Fortress Biotech FBIO Maintain Buy
(N/A)
 
 
  Details
10/30/2023 Arch Therapeutics ARTH Downgrade Neutral
(Buy)
0.60
(1.80)
200% Details
10/10/2023 Fortress Biotech FBIO Maintain Buy
(N/A)
 
 
  Details
8/30/2023 Dare Bioscience DARE Maintain Buy
(N/A)
 
 
  Details
8/22/2023 Genprex GNPX Downgrade Neutral
(Buy)
0.45
(4.40)
877.78% Details
8/3/2023 Bluejay Diagnostics BJDX Downgrade Neutral
(Buy)
5.46
(0.77)
-85.9% Details
7/17/2023 Hillstream BioPharma HILS Downgrade Neutral
(Buy)
0.38
(0.23)
-39.47% Details
5/4/2023 Citius Pharmaceuticals CTXR Maintain Buy
(N/A)
 
 
  Details
3/21/2023 Zomedica ZOM Maintain Buy
(N/A)
 
 
  Details
3/17/2023 NRx Pharmaceuticals, Inc. NRXP New Coverage Buy
(N/A)
0.69
(0.44)
-36.23% Details
3/6/2023 Arch Therapeutics ARTH Downgrade Neutral
(Buy)
4.15
(1.80)
-56.63% Details
3/3/2023 GeoVax Labs Inc. GOVX New Coverage Buy
(N/A)
0.72
(2.19)
204.17% Details
2/22/2023 Hillstream BioPharma HILS New Coverage Buy
(N/A)
1.24
(0.23)
-81.45% Details
2/13/2023 Sorrento Therapeutics SRNE Downgrade Neutral
(Buy)
0.94
(0.31)
-67.02% Details
2/6/2023 Cemtrex CETX Maintain Buy
(N/A)
 
 
  Details
1/6/2023 Zomedica ZOM New Coverage Buy
(N/A)
0.19
(0.12)
-36.84% Details
12/28/2022 Can-Fite BioPharma CANF Maintain Buy
(N/A)
 
 
  Details
12/19/2022 Smart for Life SMFL Downgrade Neutral
(Buy)
0.26
(0.78)
200% Details
11/11/2022 BioCardiAa BCDA Downgrade Neutral
(Buy)
1.92
(0.42)
-78.13% Details
9/16/2022 ADiTx Therapeutics Inc. ADTX Downgrade Neutral
(Buy)
10.39
(3.68)
-64.58% Details
8/29/2022 Smart for Life SMFL New Coverage Buy
(N/A)
0.53
(0.78)
47.17% Details
8/19/2022 Sorrento Therapeutics SRNE Maintain Buy
(N/A)
 
 
  Details
8/16/2022 ADiTx Therapeutics Inc. ADTX Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Mesoblast Limited MESO Downgrade Neutral
(Buy)
3.49
(2.06)
-40.97% Details
7/19/2022 Mesoblast Limited MESO Maintain Buy
(N/A)
 
 
  Details
7/18/2022 Dyadic International DYAI Downgrade Neutral
(Buy)
3.14
(1.45)
-53.82% Details
7/13/2022 Pluristem Therapeutics PSTI Downgrade Neutral
(Buy)
1.19
(1.00)
-15.97% Details
7/11/2022 Can-Fite BioPharma CANF Maintain Buy
(Buy)
 
 
  Details
6/29/2022 Can-Fite BioPharma CANF Maintain Buy
(Buy)
 
 
  Details
5/25/2022 Citius Pharmaceuticals CTXR Maintain Buy
(Buy)
 
 
  Details
5/25/2022 Brainstorm Cell Therapeutics BCLI Maintain Neutral
(Neutral)
 
 
  Details
5/19/2022 Adamis Pharmaceuticals ADMP Maintain Neutral
(Neutral)
 
 
  Details
5/19/2022 Adamis Pharmaceuticals ADMP Maintain Neutral
(Neutral)
 
 
  Details
5/4/2022 CytoSorbents CTSO Maintain Buy
(Buy)
 
 
  Details
5/3/2022 Lineage Cell Therapeutics Inc. LCTX Maintain Buy
(Buy)
 
 
  Details
4/29/2022 Mesoblast Limited MESO Maintain Buy
(Buy)
 
 
  Details
4/26/2022 Citius Pharmaceuticals CTXR Maintain Buy
(Buy)
 
 
  Details
4/21/2022 Bluejay Diagnostics BJDX Maintain Buy
(Buy)
 
 
  Details
4/20/2022 Dare Bioscience DARE Maintain Buy
(Buy)
 
 
  Details
4/18/2022 Citius Pharmaceuticals CTXR Maintain Buy
(Buy)
 
 
  Details
4/5/2022 ADiTx Therapeutics Inc. ADTX Maintain Buy
(Buy)
 
 
  Details
3/30/2022 BioCardiAa BCDA Maintain Buy
(Buy)
 
 
  Details
3/28/2022 Fortress Biotech FBIO Maintain Buy
(Buy)
 
 
  Details
3/24/2022 Collplant Holdings Inc. CLGN Maintain Buy
(Buy)
 
 
  Details
3/23/2022 Caladrius Biosciences CLBS Maintain Neutral
(Neutral)
 
 
  Details
3/22/2022 Adamis Pharmaceuticals ADMP Maintain Neutral
(Neutral)
 
 
  Details
3/21/2022 Dyadic International DYAI Maintain Buy
(Buy)
 
 
  Details
3/17/2022 OncoSec Medical ONCS Maintain Buy
(Buy)
 
 
  Details
3/14/2022 Sorrento Therapeutics SRNE Maintain Buy
(Buy)
 
 
  Details
3/11/2022 Lineage Cell Therapeutics Inc. LCTX Maintain Buy
(Buy)
 
 
  Details
3/10/2022 Bluejay Diagnostics BJDX Maintain Buy
(Buy)
 
 
  Details
3/9/2022 CytoSorbents CTSO Maintain Buy
(Buy)
 
 
  Details
3/8/2022 Can-Fite BioPharma CANF Maintain Buy
(Buy)
 
 
  Details
3/3/2022 BioCardiAa BCDA Maintain Buy
(Buy)
 
 
  Details
3/2/2022 Check-Cap CHEK Maintain Buy
(Buy)
 
 
  Details
3/2/2022 IsoRay, Inc. ISR Maintain Neutral
(Neutral)
 
 
  Details
3/1/2022 First Wave BioPharma, Inc. FWBI Maintain Neutral
(Neutral)
 
 
  Details
2/28/2022 Dare Bioscience DARE Maintain Buy
(Buy)
 
 
  Details
2/23/2022 Celsion Corp CLSN Maintain Neutral
(Neutral)
 
 
  Details
2/15/2022 Citius Pharmaceuticals CTXR Maintain Buy
(Buy)
 
 
  Details
2/10/2022 Anavex Life Sciences AVXL Maintain Buy
(Buy)
 
 
  Details
2/8/2022 Know Labs KNWN New Coverage Buy
(N/A)
1.59
(2.53)
59.12% Details
2/7/2022 Check-Cap CHEK Upgrade Buy
(Neutral)
0.60
(2.23)
271.67% Details
1/31/2022 Safe-T Group SFET New Coverage Buy
(N/A)
0.58
(2.86)
393.1% Details
1/26/2022 BioCardiAa BCDA Upgrade Buy
(Neutral)
1.42
(0.42)
-70.42% Details
1/12/2022 Bluejay Diagnostics BJDX New Coverage Buy
(N/A)
2.74
(0.77)
-71.9% Details
1/4/2022 Sorrento Therapeutics SRNE Maintain Buy
(Buy)
 
 
  Details
12/20/2021 Can-Fite BioPharma CANF Maintain Buy
(N/A)
 
 
  Details
11/18/2021 ADiTx Therapeutics Inc. ADTX Maintain Buy
(N/A)
 
 
  Details
9/9/2021 Citius Pharmaceuticals CTXR Maintain Buy
(N/A)
 
 
  Details
8/13/2021 Dare Bioscience DARE Maintain Buy
(N/A)
 
 
  Details
6/21/2021 Anavex Life Sciences AVXL Maintain Buy
(N/A)
 
 
  Details
5/5/2021 Arch Therapeutics ARTH New Coverage Buy
(N/A)
0.13
(1.80)
1284.62% Details
4/16/2021 BioCardiAa BCDA Downgrade Neutral
(Buy)
4.12
(0.42)
-89.81% Details
4/7/2021 Fortress Biotech FBIO Maintain Buy
(N/A)
 
 
  Details
3/17/2021 Check-Cap CHEK Downgrade Neutral
(Buy)
2.39
(0.60)
-74.9% Details
3/2/2021 BioCardiAa BCDA Maintain Buy
(N/A)
 
 
  Details
2/19/2021 Anavex Life Sciences AVXL Maintain Buy
(N/A)
 
 
  Details
2/18/2021 Citius Pharmaceuticals CTXR Maintain Buy
(N/A)
 
 
  Details
2/17/2021 Fortress Biotech FBIO Maintain Buy
(N/A)
 
 
  Details
1/6/2021 AzurRx Biopharma AZRX Downgrade Neutral
(Buy)
0.85
(3.45)
305.88% Details
10/20/2020 IsoRay, Inc. ISR Downgrade Neutral
(Buy)
0.57
(0.38)
-33.33% Details
8/24/2020 Mesoblast Limited MESO Maintain Buy
(N/A)
 
 
  Details
7/29/2020 Sigma Labs SGLB New Coverage Buy
(N/A)
2.41
(1.05)
-56.43% Details
7/28/2020 Soligenix SNGX Downgrade Neutral
(Buy)
2.13
(0.75)
-64.79% Details
7/27/2020 OncoSec Medical ONCS New Coverage Buy
(N/A)
3.19
(0.28)
-91.22% Details
7/20/2020 Sorrento Therapeutics SRNE Maintain Buy
(N/A)
 
 
  Details
7/14/2020 Celsion Corp CLSN Downgrade Neutral
(Buy)
1.29
(1.96)
51.94% Details
7/13/2020 Celsion Corp CLSN Downgrade Neutral
(Buy)
3.58
(1.96)
-45.25% Details
6/25/2020 Celsion Corp CLSN Maintain Buy
(N/A)
 
 
  Details
6/15/2020 Adamis Pharmaceuticals ADMP Upgrade Buy
(Neutral)
0.59
(0.78)
32.2% Details
6/2/2020 Sorrento Therapeutics SRNE Maintain Buy
(N/A)
 
 
  Details
5/26/2020 Sorrento Therapeutics SRNE New Coverage Buy
(N/A)
5.07
(0.31)
-93.89% Details
5/18/2020 Caladrius Biosciences CLBS Downgrade Neutral
(Buy)
1.83
(0.43)
-76.5% Details
3/31/2020 Dare Bioscience DARE Maintain Buy
(N/A)
 
 
  Details
3/9/2020 CytoSorbents CTSO Maintain Buy
(N/A)
 
 
  Details
2/27/2020 Adamis Pharmaceuticals ADMP Downgrade Neutral
(Buy)
0.55
(0.59)
7.27% Details
2/13/2020 IsoRay, Inc. ISR Maintain Buy
(N/A)
 
 
  Details
1/28/2020 Mesoblast Limited MESO Maintain Buy
(N/A)
 
 
  Details
1/27/2020 Collplant Holdings Inc. CLGN Maintain Buy
(N/A)
 
 
  Details
1/14/2020 IMAC, Holdings Inc. IMAC Downgrade Neutral
(Buy)
1.44
(1.01)
-29.86% Details
1/13/2020 IMAC, Holdings Inc. IMAC Downgrade Neutral
(Buy)
1.59
(1.44)
-9.43% Details
12/19/2019 Mesoblast Limited MESO New Coverage Buy
(N/A)
6.75
(2.06)
-69.48% Details
12/16/2019 Pluristem Therapeutics PSTI New Coverage Buy
(N/A)
3.41
(1.00)
-70.67% Details
12/5/2019 Check-Cap CHEK New Coverage Buy
(N/A)
1.36
(2.39)
75.74% Details
11/26/2019 Adamis Pharmaceuticals ADMP Maintain Buy
(N/A)
 
 
  Details
11/4/2019 Collplant Holdings Inc. CLGN New Coverage Buy
(N/A)
4.67
(5.37)
14.99% Details
10/17/2019 Dyadic International DYAI New Coverage Neutral
()
6.66
(1.45)
-78.23% Details
10/15/2019 Dyadic International DYAI New Coverage Buy
(N/A)
6.39
(6.66)
4.23% Details
9/24/2019 MYnd Analytics MYND Downgrade Neutral
(Buy)
1.17
(5.10)
335.9% Details
9/17/2019 BioCardiAa BCDA New Coverage Buy
(N/A)
5.05
(0.42)
-91.68% Details
9/6/2019 Citius Pharmaceuticals CTXR New Coverage Buy
(N/A)
1.19
(0.79)
-33.61% Details
8/26/2019 Fortress Biotech FBIO New Coverage Buy
(N/A)
1.58
(1.75)
10.76% Details
8/26/2019 Athersys ATHX New Coverage Buy
(N/A)
1.27
(0.10)
-92.13% Details
8/12/2019 ADMA Biologics ADMA Downgrade Neutral
(Buy)
3.48
(5.26)
51.15% Details
8/5/2019 Soligenix SNGX New Coverage Buy
(N/A)
1.23
(2.13)
73.17% Details
8/5/2019 IMAC, Holdings Inc. IMAC New Coverage Buy
(N/A)
3.50
(1.59)
-54.57% Details
8/5/2019 Celsion Corp CLSN New Coverage Buy
(N/A)
1.71
(3.58)
109.36% Details
7/24/2019 Anavex Life Sciences AVXL New Coverage Buy
(N/A)
2.57
(5.01)
94.94% Details
7/2/2019 Adamis Pharmaceuticals ADMP New Coverage Buy
(N/A)
1.30
(0.78)
-40% Details
7/1/2019 IsoRay, Inc. ISR New Coverage Buy
(N/A)
0.42
(0.57)
35.71% Details
4/12/2019 MYnd Analytics MYND New Coverage Buy
(N/A)
1.32
(1.17)
-11.36% Details
2/27/2019 Caladrius Biosciences CLBS New Coverage Buy
(N/A)
4.20
(1.83)
-56.43% Details
1/3/2019 Jaguar Animal Health JAGX New Coverage Buy
(N/A)
0.27
(0.06)
-77.78% Details
12/18/2018 Brainstorm Cell Therapeutics BCLI New Coverage Buy
(N/A)
3.05
(0.33)
-89.18% Details